English Formate dehydrogenase (FDH) catalyzes the reversible bioconversion of formate and NAD+ to produce carbon dioxide and NADH. FDH is biotechnologically important because it
Author: Webmaster
BC Faculty Seminar: January 4, 2024
BC Faculty Seminar “The versatility of MarR domain in the regulation of phenolic compound utilization” by Assoc. Prof. Danaya Pakotiprapha Department of Biochemistry, Faculty of
Preclinical evidence for anaplastic lymphoma kinase inhibitors as novel therapeutic treatments for cholangiocarcinoma
Introduction: Bile duct cancer (cholangiocarcinoma, CCA) has a poor prognosis for patients, and despite recent advances in targeted therapies for other cancer types, it is still
BC Special Seminar: January 24, 2024
“Application of highly immunodeficient mice for cancer research and drug development” by Professor Seiji Okada, MD, PhD “Establishment and application of Patient-derived xenograft and cell
MicroRNA expression profiles associated with the metastatic ability of MDA‑MB‑231 breast cancer cells
Breast cancer is an important worldwide public health concern and its incidence increases every year. MicroRNAs (miRs/miRNAs) are small non-coding RNAs that control gene expression
Anti-Xanthine Oxidase 5′-Hydroxyhericenes A-D from the Edible Mushroom Hericium erinaceus and Structure Revision of 3-[2,3-Dihydroxy-4-(hydroxymethyl)tetrahydrofuran-1-yl]-pyridine-4,5-diol
Hericium erinaceus is an edible mushroom with diverse pharmaceutical applications. Although this mushroom is an attractive source of natural products for cancer treatment, little is
Proteomic analysis of holocarboxylase synthetase deficient-MDA-MB-231 breast cancer cells revealed the biochemical changes associated with cell death, impaired growth signaling, and metabolism
Holocarboxylase synthetase (HLCS) is the enzyme that regulates biotin carboxylase activities, and plays an important role in cancer metabolism. Here, we investigated the global biochemical
BC Special Seminar: January 15, 2024
BC Special Seminar “Science Careers in Pharma Beyond the Bench” by Chatarin (Chad) Wangsanuwat, Ph.D. University of California, Santa Barbara Current position: Senior Scientist, Moderna
BC Special Seminar: January 24, 2024
BC Special Seminar “Science Careers in Pharma Beyond the Bench” by Dr. Oleg Lavrukhin Regional Field Medical Lead Sanofi US Time: 1:00-2:00 pm Venue:
BC Faculty Seminar: January 10, 2024
BC Faculty Seminar “Development of smart nano-delivery platforms targeting colorectal cancer for personalized medicine: A showcase of ZY-444 small molecule targeting pyruvate carboxylase.” by Prof. Sarawut